Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva Says 2018 Profit Will Keep Falling as Generic Drug Slump Persists - Bloomberg
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
$40 million incentive lures global pharmaceutical giant to Parsippany
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Roundup: Pharma news from HLTH 2022 | pharmaphorum
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States | Business Wire
Teva Pharmaceuticals Moving U.S. Headquarters To New Jersey
Pharma giant Teva promises to create over 800 jobs in N.J. Are they worth $40M? - nj.com
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Teva Pharmaceutical to lay off 14,000 globally over 2 years | Business | heraldandnews.com
Here's Why Teva Pharma Stock Is Soaring Today
TEVA | Market Realist
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology
Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
